Diabetes and hyperglycemia: Strict glycemic control

Critical Care Medicine

Volumn 34, Issue SUPPL. 9, 2006, Pages

  Turina, Matthias ^a,b   Christ Crain, Mirjam ^c   Polk Jr , Hiram C ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Blood glucose; Critical illness; Diabetes; Hyperglycemia; Hypoglycemia; Sepsis syndrome; Stress

Indexed keywords

CORTICOSTEROID; INSULIN;

BLOOD GLUCOSE MONITORING; CRITICAL ILLNESS; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE; MEDLINE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEPSIS;

BLOOD GLUCOSE; CRITICAL CARE; CRITICAL ILLNESS; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE UNITS;

EID: 33747387245     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000231887.84751.04     Document Type: Review

References (95)

1. Nathan DM: Clinical practice: Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med 2002; 347:1342-1349
2. Harris M, Cowie C (Eds): Prevalence and Incidence of Non-Insulin- Dependent Diabetes. Bethesda, National Institutes of Health, 1995
3. Centers for Disease Control and Prevention: National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. Atlanta, US Department of Health and Human Services, Centers for Disease Control and Prevention, 2003
4. Mokdad AH, Ford ES, Bowman BA, et al: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289:76-79
5. Sullivan PW, Morrato EH, Ghushchyan V, et al: Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care 2005; 28:1599-1603
6. Onkamo P, Vaananen S, Karvonen M, et al: Worldwide increase in incidence of Type I diabetes: The analysis of the data on published incidence trends. Diabetologia 1999; 42:1395-1403
7. Engelgau MM, Geiss LS, Saaddine JB, et al: The evolving diabetes burden in the United States. Ann Intern Med 2004; 140:945-950
8. Geiss LS, Herman WH, Smith PJ: Mortality among persons with non-insulin dependent diabetes. In: Diabetes in America. Second Edition. Harris M, Cowie C, Stern M, et al (Eds). Bethesda, National Institutes of Health, 1995, pp 233-258
9. Manuel DG, Schultz SE: Diabetes health status and risk factors. In: Diabetes in Ontario: An Institute for Clinical Evaluative Sciences Practice Atlas. Toronto, Canadian Diabetes Association, 2002, 4.77- 4.94
10. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(Suppl 1):S5-S20
11. Honeycutt AA, Boyle JP, Broglio KR, et al: A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050. Health Care Manag Sci 2003; 6:155-164
12. McCowen KC, Malhotra A, Bistrian BR: Stress-induced hyperglycemia. Crit Care Clin 2001; 17:107-124
13. Finney SJ, Zekveld C, Elia A, et al: Glucose control and mortality in critically ill patients. JAMA 2003; 290:2041-2047
14. Grey NJ, Perdrizet GA: Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004; 10(Suppl 2):46-52
15. Krinsley JS: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78:1471-1478
16. Krinsley JS: Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79:992-1000
17. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367
18. Latham R, Lancaster AD, Covington JF, et al: The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001; 22:607-612
19. Capes SE, Hunt D, Malmberg K, et al: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355:773-778
20. McAlister FA, Majumdar SR, Blitz S, et al: The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 2005; 28:810-815
21. Bhisitkul DM, Morrow AL, Vinik AI, et al: Prevalence of stress hyperglycemia among patients attending a pediatric emergency department. J Pediatr 1994; 124:547-551
22. Valerio G, Franzese A, Carlin E, et al: High prevalence of stress hyperglycaemia in children with febrile seizures and traumatic injuries. Acta Paediatr 2001; 90:618-622
23. Xu F, Yang X, Lu Z, et al: Evaluation of glucose metabolic disorder: Insulin resistance and insulin receptors in critically ill children. Chin Med J (Engl) 1996; 109:807-809
24. Turner R, Stratton I, Horton V, et al: UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997; 350:1288-1293
25. Atkinson MA, Eisenbarth GS: Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 2001; 358:221-229
26. Boord JB, Graber AL, Christman JW, et al: Practical management of diabetes in critically ill patients. Am J Respir Crit Care Med 2001; 164:1763-1767
27. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2005; 365:1415-1428
28. Stumvoll M, Goldstein BJ, van Haeften TW: Type 2 diabetes: Principles of pathogenesis and therapy. Lancet 2005; 365:1333-1346
29. Sinha R, Fisch G, Teague B, et al: Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002; 346:802-810
30. Dinneen S, Gerich J, Rizza R: Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 1992; 327:707-713
31. Baron AD, Brechtel G, Wallace P, et al: Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol 1988; 255:E769-E774
32. Mizock BA: Alterations in fuel metabolism in critical illness: Hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001; 15:533-551
33. Klip A, Tsakiridis T, Marette A, et al: Regulation of expression of glucose transporters by glucose: A review of studies in vivo and in cell cultures. FASEB J 1994; 8:43-53
34. Mizock BA: Alterations in carbohydrate metabolism during stress: A review of the literature. Am J Med 1995; 98:75-84
35. Clerici C, Matthay MA: Hypoxia regulates gene expression of alveolar epithelial transport proteins. J Appl Physiol 2000; 88:1890-1896
36. Pekala P, Marlow M, Heuvelman D, et al: Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J Biol Chem 1990; 265:18051-18054
37. Sanchez-Alvarez R, Tabernero A, Medina JM: Endothelin-1 stimulates the translocation and upregulation of both glucose transporter and hexokinase in astrocytes: Relationship with gap junctional communication. J Neurochem 2004; 89:703-714
38. Vanhorebeek I, Langouche L, Van den Berghe G: Glycemic and nonglycemic effects of insulin: How do they contribute to a better outcome of critical illness? Curr Opin Crit Care 2005; 11:304-311
39. Rolih CA, Ober KP: The endocrine response to critical illness. Med Clin North Am 1995; 79:211-224
40. Wolfe RR: Herman Award Lecture, 1996: Relation of metabolic studies to clinical nutrition. The example of burn injury. Am J Clin Nutr 1996; 64:800-808
41. Bastard JP, Maachi M, Van Nhieu JT, et al: Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002; 87:2084-2089
42. Borst SE: The role of TNF-alpha in insulin resistance. Endocrine 2004; 23:177-182
43. Rotter V, Nagaev I, Smith U: Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003; 278:45777-45784
44. Borst SE, Lee Y, Conover CF, et al: Neutralization of tumor necrosis factor-alpha reverses insulin resistance in skeletal muscle but not adipose tissue. Am J Physiol Endocrinol Metab 2004; 287:E934-E938
45. Cheung AT, Wang J, Ree D, et al: Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase. Diabetes 2000; 49:810-819
46. Ma Y, Toth B, Keeton AB, et al: Mechanisms of hemorrhage-induced hepatic insulin resistance: Role of tumor necrosis factor-alpha. Endocrinology 2004; 145:5168-5176
47. Bessey PQ, Brooks DC, Black PR, et al: Epinephrine acutely mediates skeletal muscle insulin resistance. Surgery 1983; 94:172-179
48. James DE, Burleigh KM, Kraegen EW: In vivo glucose metabolism in individual tissues of the rat: Interaction between epinephrine and insulin. J Biol Chem 1986; 261:6366-6374
49. Smith TR, Elmendorf JS, David TS, et al: Growth hormone-induced insulin resistance: Role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4. Am J Physiol 1997; 272:E1071-E1079
50. Venkatesan N, Lim J, Bouch C, et al: Dexamethasone-induced impairment in skeletal muscle glucose transport is not reversed by inhibition of free fatty acid oxidation. Metabolism 1996; 45:92-100
51. Rosmarin DK, Wardlaw GM, Mirtallo J: Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose. Nutr Clin Pract 1996; 11:151-156
52. Desai D, March R, Watters JM: Hyperglycemia after trauma increases with age. J Trauma 1989; 29:719-723
53. Stuart CA, Shangraw RE, Prince MJ, et al: Bed-rest-induced insulin resistance occurs primarily in muscle. Metabolism 1988; 37:802-806
54. Vanhorebeek I, De Vos R, Mesotten D, et al: Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005; 365:53-59
55. Boger RH, Maas R, Schulze F, et al: Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality. Clin Chem Lab Med 2005; 43:1124-1129
56. Siroen MP, van Leeuwen PA, Nijveldt RJ, et al: Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: A possible explanation of reduced morbidity and mortality? Crit Care Med 2005; 33:504-510
57. Langouche L, Vanhorebeek I, Vlasselaers D, et al: Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005; 115:2277-2286
58. Umpierrez GE, Isaacs SD, Bazargan N, et al: Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87:978-982
59. Coursin DB, Connery LE, Ketzler JT: Perioperative diabetic and hyperglycemic management issues. Crit Care Med 2004; 32:S116-S125
60. Van den Berghe G: Neuroendocrine pathobiology of chronic critical illness. Crit Care Clin 2002; 18:509-528
61. Kermani A, Garg A: Thiazolidinedione-associated congestive heart failure and pulmonary edema. Mayo Clin Proc 2003; 78:1088-1091
62. Kitabchi AE, Umpierrez GE, Murphy MB, et al: Hyperglycemic crises in diabetes. Diabetes Care 2004; 27(Suppl 1):S94-S102
63. Pitteloud N, Philippe J: Characteristics of Caucasian type 2 diabetic patients during ketoacidosis and at follow-up. Schweiz Med Wochenschr 2000; 130:576-582
64. Umpierrez GE, Kitabchi AE: Diabetic ketoacidosis: Risk factors and management strategies. Treat Endocrinol 2003; 2:95-108
65. English P, Williams G: Hyperglycaemic crises and lactic acidosis in diabetes mellitus. Postgrad Med J 2004; 80:253-261
66. Magee MF, Bhatt BA: Management of decompensated diabetes: Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome. Crit Care Clin 2001; 17:75-106
67. Grundy SM, Benjamin IJ, Burke GL, et al: Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation 1999; 100:1134-1146
68. Malmberg K, Ryden L, Efendic S, et al: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. J Am Coll Cardiol 1995; 26:57-65
69. Malmberg K, Norhammar A, Wedel H, et al: Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction. Long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99:2626-2632
70. Nathan DM, Cleary PA, Backlund JY, et al: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353:2643-2653
71. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329:977-986
72. Perner A, Nielsen SE, Rask-Madsen J: High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Med 2003; 29:642-645
73. Turina M, Fry DE, Polk HC Jr: Acute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects. Crit Care Med 2005; 33:1624-1633
74. Khaodhiar L, McCowen K, Bistrian B: Perioperative hyperglycemia, infection or risk? Curr Opin Clin Nutr Metab Care 1999; 2:79-82
75. Marfella R, Nappo F, De Angelis L, et al: The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia 2000; 43:571-575
76. Capes SE, Hunt D, Malmberg K, et al: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke 2001; 32:2426-2432
77. Norhammar AM, Ryden L, Malmberg K: Admission plasma glucose: Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999; 22:1827-1831
78. Zindrou D, Taylor KM, Bagger JP: Admission plasma glucose: an independent risk factor in nondiabetic women after coronary artery bypass grafting. Diabetes Care 2001; 24:1634-1639
79. Michaud LJ, Rivara FP, Longstreth WT Jr, et al: Elevated initial blood glucose levels and poor outcome following severe brain injuries in children. J Trauma 1991; 31:1356-1362
80. Gore DC, Chinkes D, Heggers J, et al: Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001; 51:540-544
81. Vincent JL, Abraham E, Annane D, et al: Reducing mortality in sepsis: new directions. Crit Care 2002; 6(Suppl 3):S1-S18
82. Pittas AG, Siegel RD, Lau J: Insulin therapy for critically ill hospitalized patients: A meta-analysis of randomized controlled trials. Arch Intern Med 2004; 164:2005-2011
83. Van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461
84. Dhatariya K: Hyperglycemia in acute illness. JAMA 2003; 289:1244
85. Evans TW: Hemodynamic and metabolic therapy in critically ill patients. N Engl J Med 2001; 345:1417-1418
86. Montori VM, Bistrian BR, McMahon MM: Hyperglycemia in acutely ill patients. JAMA 2002; 288:2167-2169
87. Van den Berghe G, Wouters PJ, Bouillon R, et al: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31:359-366
88. Van den Berghe G: Beyond diabetes: Saving lives with insulin in the ICU. Int J Obes Relat Metab Disord 2002; 26(Suppl 3):S3-S8
89. Goldberg PA, Siegel MD, Sherwin RS, et al: Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 2004; 27:461-467
90. Moeniralam H, Spronk P, Graat M, et al: Tight glycemic control increases the incidence of hypoglycemia in intensive care unit patients. Abstr. Crit Care 2005; 9:S162
91. Kanji S, Singh A, Tierney M, et al: Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Med 2004; 30:804-810
92. Markovitz LJ, Wiechmann RJ, Harris N, et al: Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocr Pract 2002; 8:10-18
93. Preiser JC, Devos P, Van den Berghe G: Tight control of glycaemia in critically ill patients. Curr Opin Clin Nutr Metab Care 2002; 5:533-537
94. De Block C, Rogiers P, Keenoy B, et al: Intensive insulin therapy in the intensive care unit: Assessment by continuous glucose monitoring. Abstr. Crit Care 2005; 9:S159
95. Farmer M, Kornfeld H: Assessment of glycemic control in critical illness using a continuous glucose monitoring system. Abstr. Chest 2004; 126:873